Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf vs Cyclosporine for CLAD prevention after lung transplantation
NCT02936505Active, not recruiting
- Sponsor
- Region Västra Götaland
- Start
- Oct 2016
- Primary completion
- Oct 2025
- Modality
- Orthosteric Ligands
- Countries
- 4
01
Overview
Randomised, open-label trial of tacrolimus + Wuzhi capsule in chronic lung allograft dysfunction (CLAD), sponsored by Region Västra Götaland. Started Oct 2016; status: active, not recruiting.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
chronic lung allograft dysfunction (CLAD)
Beyond the preview
Go deeper on NCT02936505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02936505.